Ver mas grande
ELISA Kit for Fibulin 3 (FBLN3)
CC-SEF422Hu
Producto nuevo
48T, 96T, 96T×5, 96T×10, 96T×100
Comprando este producto generará 7 Biopuntos. Su cesta contiene un total 7 Biopuntos puede ser convertido en un Biobonos Descuento 28.00EUR.
Hoja técnica
| Size | 96T |
| Storage Conditions | -20°C |
| Shipping Conditions | Entre 4°C y 8°C |
| Applications | Enzyme-linked immunosorbent assay for Antigen Detection. |
| Detection Range | 1.56-100ng/mL |
| Sensitivity | The minimum detectable dose of this kit is typically less than 0.64ng/mL |
| Research Area | Metabolic pathway |
| Organism species | Homo sapiens (Human) |
| Alternative Names | EFEMP1 |
| Item Name | Fibulin 3 |
| Assay Length | 3h |
| Method | Double-antibody Sandwich |
| Sample Type | Serum, plasma, urine and other biological fluids |
| Formato | 48T, <i>96T</i>, 96T×5, 96T×10, 96T×100 |
| Test Principle | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Fibulin 3 (FBLN3). Standards or samples are then added to the appropriate microtiter plate we |
| Assay procedure summary | 1. Prepare all reagents, samples and standards |
| UniProt ID | Q12805 |
Más información
CITATIONS
Fibulin-3 as a Blood and Effusion Biomarker for Pleural Mesothelioma;YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.;Role of fibulin-3 in lung cancer: In vivo and in vitro analyses;Discovery of new biomarkers for malignant mesothelioma;DIAGNOSIS OF CELL PROLIFERATIVE DISEASES;Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma;Value of plasma and pleural effusion fibulin-3 levels in the diagnosis of malignant pleural mesothelioma effusions;Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma;Fibulin-3 levels in malignant pleural mesothelioma are associated with prognosis but not diagnosis;Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.;Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational study ;HMGB1 and its hyperacetylated isoform are sensitive and specific serum biomarkers to detect asbestos exposure and to identify mesothelioma patients;Diagnostic and Prognostic Biomarkers in the Rational Assessment of Mesothelioma (DIAPHRAGM) study: protocol of a prospective, multicentre, observational …;Comparison of the Diagnostic Performance of Fibulin-3 and Mesothelin in Patients with Pleural Effusions from Malignant Mesothelioma.;A Novel Panel of Serum Biomarkers for MPM Diagnosis.;Association of fibulin-3 concentrations with the presence and severity of knee osteoarthritis: A cross-sectional study;Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population;Placental protein 14 as a potential biomarker for diagnosis of preterm premature rupture of membranes;The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion;Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin (MRP8/14) and disease activity in rheumatoid arthritis patients treated with …;Prediction of pneumoconiosis by serum and urinary biomarkers in workers exposed to asbestos-contaminated minerals;